Kaposi's sarcoma associated with chronic myeloid leukemia and imatinib mesylate therapy

被引：2

作者：

D'Addona, Matteo ^{[1
]}

Pezzullo, Luca ^{[1
]}

Giudice, Valentina ^{[1
,2
]}

Serio, Bianca ^{[1
]}

Baldi, Carlo ^{[3
]}

Zeppa, Pio ^{[2
,3
]}

Selleri, Carmine ^{[1
,2
]}

机构：

[1] Univ Hosp San Giovanni Dio & Ruggi dAragona, Hematol & Transplant Ctr, Salerno, Italy

[2] Univ Salerno, Dept Med Surg & Dent, Baronissi, Italy

[3] Univ Hosp San Giovanni Dio & Ruggi dAragona, Anat Pathol, Salerno, Italy

来源：

CLINICAL CASE REPORTS | 2022年 / 10卷 / 06期

关键词：

BCR-ABL; inhibitor; chronic myeloid leukemia; Kaposi's sarcoma; INTERFERON-ALPHA;

D O I：

10.1002/ccr3.5919

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Kaposi's sarcoma is associated with immunosuppression and human herpesvirus 8 infection, while rarely described in myeloid malignancies. Here, we illustrate a rare case of chronic myeloid leukemia treated with imatinib, a tyrosine kinase inhibitor, who developed a human herpesvirus 8-related Kaposi's sarcoma.

引用

页数：4

共 50 条

[1] Kaposi's Sarcoma in a Patient Treated With Imatinib Mesylate for Chronic Myeloid Leukemia
Campione, Elena
Diluvio, Laura
Paterno, Evelin J.
Di Marcantonio, Dely
Francesconi, Arianna
Terrinoni, Alessandro
Orlandi, Augusto
Chimenti, Sergio
CLINICAL THERAPEUTICS, 2009, 31 (11) : 2565 - 2569
[2] Therapy with Imatinib Mesylate for Chronic Myeloid Leukemia
Arora, Brijesh
Kumar, Lalit
Kumari, Mamta
Sharma, Atul
Wadhawa, Jyoti
Kochupillai, V
INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2005, 26 (02) : 5 - +
[3] Granulocytic Sarcoma giant in chronic myeloid leukemia during imatinib mesylate therapy
Cavalheiro, RDR
Vicari, P
Morselli, FM
Ommati, LVM
Rosa, FDF
Oliveira, JSR
AMERICAN JOURNAL OF HEMATOLOGY, 2006, 81 (01) : 76 - 77
[4] Results of imatinib mesylate therapy in chronic myeloid leukemia
Altintas, Abdullah
Cil, Timucin
Ayyildiz, Orhan
Kaplan, Mehmet A.
Isikdogan, Abdurrahman
Muftuoglu, Ekrem
Atay, Ahmet E.
ANNALS OF ONCOLOGY, 2006, 17 : 211 - 211
[5] Imatinib Mesylate in Chronic Myeloid Leukemia
Mishra, Pravas
INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2007, 28 (01) : 5 - 6
[6] Reduced dose imatinib mesylate therapy for chronic myeloid leukemia
Zipin, D
Savage, DG
LEUKEMIA & LYMPHOMA, 2004, 45 (11) : 2363 - 2364
[7] Chronic myeloid leukemia-associated membranoproliferative glomerulonephritis that responded to imatinib mesylate therapy
Dwyer, J. P.
Yates, K. M.
Sumner, E. L.
Stone, W. J.
Wang, Y.
Koury, M. J.
Fogo, A. B.
Zent, R.
CLINICAL NEPHROLOGY, 2007, 67 (03) : 176 - 181
[8] Spotlight on Imatinib Mesylate in Chronic Myeloid Leukemia
Monique P. Curran
Katherine F. Croom
Karen L. Goa
BioDrugs, 2004, 18 : 207 - 210
[9] Treatment of chronic myeloid leukemia with imatinib mesylate
Ohno R.
International Journal of Clinical Oncology, 2006, 11 (3) : 176 - 183
[10] Spotlight on imatinib mesylate in chronic myeloid leukemia
Curran, MP
Croom, KF
Goa, KL
BIODRUGS, 2004, 18 (03) : 207 - 210

← 1 2 3 4 5 →